Defacer Attack on Religious Site
Previously, we explore and elaborate on the importance of defacement monitoring in the public sector (government) and private sector. The last private case is airline industry.
Now, the new defacement case we would like to explore is the defacer's attack on a religious site.
The particular defacer is a group that demands the release of their leader that was arrested after participating in a protest against the killing of another politician.
Disturbing images and offensive phrases might be displayed in the process, as well as a signature of sorts, to show who was responsible for the defacement.
As well, the group expressing their principles that thrilling others, such as “In a world where we do not have a right to live, we will not give anyone the right to live.”
Based on their statement above, we may conclude that the group is very harsh in articulating their intention which looks concrete in defacing a religious site.
Their strength of the attack is at the same level of dangerousness as the attack to government site.
Even though it is a religious site (not a type of government site), there is still a possibility to be hacked by one kind of defacer mentioned above.
The web defacement that happened to the religious site shall be treated better if we can detect it faster. A tool of defacement monitoring helps us in preventing the damage of functionalities and the brand name of our web. One name of already-provided service in the market is SentryPage.
SentryPage is a tool to monitor a defacement. The features as follows:
- SentryPage monitor your webpage for unusual activities like defacement
- SentryPage has an attack signature database to increase the probability of detecting defacement activity on your site.
- SentryPage also tracks all forms of unidentified external resources (such as images that suddenly exist and do not come from on your site's server) as a form of detecting unusual activities.
In convincing you of the performance of SentryPage, you can try our service by taking a 30-day trial first.